This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Clinical Trials Remove eCommerce Remove THC Related Topics
Pets Cannabinoids Tincture Sleep History CBD Collective Topical Data Compliance More Related Topics >
article thumbnail

cbdMD Therapeutics Releases Research Plan

Cannabis Law Report

JULY 8, 2021

cbdMD began its first phase of research in the Fall of 2020, with its first in vivo animal study and clinical trials. produced, THC-free 1 CBD products. grown, THC-free 1 CBD oil products, please visit www.cbdmd.com , follow cbdMD on Instagram and Facebook, or visit one of the 6,000 retail outlets that carry cbdMD products.

Research and Development 111
Research and Development Pets Cannabinoids eCommerce 111
article thumbnail

The Valens Company Achieves Access to GMP Manufacturing in Australia & Expands International Footprint to Asia-Pacific through Exclusive Partnership with Epsilon Healthcare

Cannabis Law Report

SEPTEMBER 8, 2021

The partnership is reflected in the terms of the Binding Heads of Agreement between the Epsilon, THC Pharma (the Epsilon’s wholly owned subsidiary, and owner of the Southport Facility), Valens, and Valens Australia Pty Ltd (Valens’ wholly owned subsidiary) (the “ Agreement “). Schedule 1. together, the “Definitive Agreements”).

Access 97
Access Research and Development Medicine THC 97
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 24,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024